Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells. It primarily affects lymph nodes in the head, face, and neck region. Accurate coding with ICD-10 Code C83.31 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate treatment and care.
ICD-10 Code C83.31 specifically denotes Diffuse large B-cell lymphoma affecting the lymph nodes in the head, face, and neck. This code is utilized in clinical documentation and billing when diagnosing patients with this aggressive form of lymphoma, ensuring accurate representation of the patient's condition and facilitating appropriate treatment and reimbursement.
Diffuse large B-cell lymphoma is a hematological malignancy that arises from B-lymphocytes and is characterized by large, atypical cells. It can present as a rapidly enlarging mass in the lymph nodes of the head, face, and neck, necessitating prompt medical evaluation and intervention.
ICD-10 Code C83.31 is integral in SOAP notes for documenting the clinical presentation, assessment, and treatment of patients with Diffuse large B-cell lymphoma. It aids in capturing the severity and specifics of the condition in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C83.31 connects subjective patient reports and objective clinical findings to a formal diagnosis of Diffuse large B-cell lymphoma. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Prompt treatment for Diffuse large B-cell lymphoma is critical due to its aggressive nature. Hospitalization may be required for intensive therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.31 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 77014 | Radiologic examination, lymphatic system, including lymphangiography. |
Common Questions About Using ICD-10 Code C83.31 for Diffuse large B-cell lymphoma, nodes of head, face, and neck
What are the common symptoms of Diffuse large B-cell lymphoma?
Common symptoms include swollen lymph nodes, unexplained weight loss, fever, night sweats, and fatigue. Patients may present with rapidly enlarging masses in the head, face, or neck.
How is Diffuse large B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of large B-cells.
What treatments are available for Diffuse large B-cell lymphoma?
Treatment often includes chemotherapy regimens such as R-CHOP, and may also involve radiation therapy depending on the stage and location of the disease.
Is Diffuse large B-cell lymphoma curable?
Diffuse large B-cell lymphoma is considered aggressive but can be curable in many cases, especially with early diagnosis and appropriate treatment.
Clinical Notes
SOAP notes
DAP notes
AI medical notes